Treatment of neurons with beta-amyloid, a major pathogenic protein in AD, was shown to disrupt the CDK5-p27 interaction and to result in cytoplasmic accumulation of CDK5 (Zhang et al., 2010). This evidence concerns the gene CDK5 and Alzheimer disease.